千亿巨头大动作

中国基金报
Oct 17, 2025

【导读】翰森制药与罗氏达成重磅合作,潜在交易总额达15.3亿美元  中国基金报记者卢鸰  “中国最牛医药夫妻档”之一的钟慧娟又有大动作。  10月17日早间,翰森制药公告称,将其在研的CDH17靶向抗体偶联药物(ADC)HS-20110在大中华区以外的全球权益,授权给知名跨国医药巨头罗氏的子公司。该产品目前正在中国和美国开展用于治疗结直肠癌(CRC)及其他实体瘤的全球I期临床试验。  罗氏于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10